Latest News

Lucila Ohno-Machado, MD, MBA, PhD, and Tsung-Ting Kuo, PhD, have been awarded a four-year, $2.7 million grant from the National Library of Medicine to develop novel methods for explaining clinical AI models. The project, "Supervised Weighted Distances: Patient Similarity to Explain Clinical AI Models," will create algorithms and interactive visualization tools that help clinicians understand AI predictions by showing how individual patients compare to similar past cases with known outcomes. Running from September 2025 through August 2029, the research aims to increase trust and adoption of AI in clinical settings by making machine learning recommendations more transparent and interpretable for healthcare providers.

Yale's S-index project, led by Hua Xu, PhD, wins $15,000 in phase 1 of the NIH's $1 million Data Sharing Challenge and advances to phase 2 for the grand prize with innovative metrics that incentivize quality biomedical data sharing.

Two new research computing platforms, Hopper and SpinupPlus, are now available for analysis of large-scale, high-risk data. These platforms increase Yale’s highly secure research computing infrastructure.

Highlighting recent graduates of Yale’s Computational Biology and Biomedical Informatics (CBB) Ph.D. Program whose cutting-edge research is driving innovation in biomedical science and data-driven discovery.

Highlighting recent graduates of Yale’s Computational Biology and Biomedical Informatics (CBB) Ph.D. Program whose cutting-edge research is driving innovation in biomedical science and data-driven discovery.

Hua Xu, PhD, has received a $977,811 administrative supplement from the National Institute of Mental Health to support his project on coordinating individually measured phenotypes for mental health research.

BIDS faculty, postdocs, students and research staff contributed a rich range of posters, talks, and exhibits at the 2025 AI at Yale Symposium.

Andrew Loza, MD, PhD, has received the 2024 Hartwell Award, which provides $300,000 over three years to support innovative biomedical research benefiting children’s health.

Only 3% of eligible U.S. adults receive prescriptions for weight loss medications, according to research from Yale School of Medicine.